Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
3.510
-0.100 (-2.77%)
Jul 30, 2026, 3:00 PM CST
Guizhou Yibai Pharmaceutical Company Description
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China.
The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, gynecological, tonic, oncology, orthopedics, gastroenterology, andrology and urology.
Guizhou Yibai Pharmaceutical Co., Ltd. was founded in 1995 and is based in Guiyang, China.
Guizhou Yibai Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,832 |
| CEO | Ya Qi Dou |
Contact Details
Address: No. 220-1, Baiyun Avenue Guiyang, 550008 China | |
| Phone | 86 85 1847 05590 |
| Website | gzcci.com |
Stock Details
| Ticker Symbol | 600594 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001H03 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ya Qi Dou | Vice Chairman, Accounting Supervisor and Deputy GM |
| Zhou Yi | Deputy General Manager |
| Xianti Zeng | Financial Director |
| Jiang Xianhong | Deputy GM and Secretary to the Board |
| Jian Pu | Deputy General Manager |
| Li Dong Wang | Deputy General Manager |
| Hua Wen Wang | Deputy General Manager |